| 104.9 -11.16 (-9.62%) | 01-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 138.8 | 1-year : | 162.12 |
| Resists | First : | 118.83 | Second : | 138.8 |
| Pivot price | 101.36  |
|||
| Supports | First : | 97.35 | Second : | 84.08 |
| MAs | MA(5) : | 104 |
MA(20) : | 98.13 |
| MA(100) : | 79.23 |
MA(250) : | 53.19 |
|
| MACD | MACD : | 3.5 |
Signal : | 2.6 |
| %K %D | K(14,3) : | 72.9 |
D(3) : | 70.7 |
| RSI | RSI(14): 55.2 |
|||
| 52-week | High : | 118.83 | Low : | 20.44 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ GRAL ] has closed below upper band by 34.8%. Bollinger Bands are 3.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 114.3 - 114.86 | 114.86 - 115.32 |
| Low: | 102.85 - 103.57 | 103.57 - 104.15 |
| Close: | 103.9 - 104.98 | 104.98 - 105.86 |
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
Fri, 23 Jan 2026
GRAIL (NASDAQ:GRAL) Trading Down 7.7% - Here's Why - MarketBeat
Thu, 22 Jan 2026
GRAIL (NASDAQ:GRAL) Reaches New 12-Month High - What's Next? - MarketBeat
Wed, 21 Jan 2026
GRAIL, Inc. (GRAL): A Bull Case Theory - MSN
Tue, 20 Jan 2026
GRAIL Inc (GRAL) Shares Up 4.37% on Jan 20 - GuruFocus
Tue, 20 Jan 2026
GRAIL Inc. - Illumina's Divested Holy Grail (NASDAQ:GRAL) - Seeking Alpha
Fri, 02 Jan 2026
Grail Inc (GRAL) Climbs 380% on Strong Optimism for Cancer Detection Kit - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 39 (M) |
| Shares Float | 33 (M) |
| Held by Insiders | 10.2 (%) |
| Held by Institutions | 65.2 (%) |
| Shares Short | 5,200 (K) |
| Shares Short P.Month | 5,330 (K) |
| EPS | -10.66 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 61.93 |
| Profit Margin | -286.5 % |
| Operating Margin | -346.2 % |
| Return on Assets (ttm) | -11.1 % |
| Return on Equity (ttm) | -16.9 % |
| Qtrly Rev. Growth | 26.2 % |
| Gross Profit (p.s.) | -1.73 |
| Sales Per Share | 3.63 |
| EBITDA (p.s.) | -8.97 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -329 (M) |
| Levered Free Cash Flow | -59 (M) |
| PE Ratio | -9.85 |
| PEG Ratio | 0 |
| Price to Book value | 1.69 |
| Price to Sales | 28.83 |
| Price to Cash Flow | -12.44 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|